EUVIMEDEUVIMED entdecken
Crossref

Indazole as a Phenol Bioisostere: Structure–Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists

Judith Lüken, Gunnar Goerges iD, Nadine Ritter, Paul Disse, Julian A Schreiber, Judith Schmidt, Bastian Frehland, Dirk Schepmann, Guiscard Seebohm, Bernhard Wünsch iD

Journal of Medicinal Chemistry · 24.08.2023 · 66 (16) · 11573-11588

DOI: 10.1021/acs.jmedchem.3c01161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 15.08.2023. Verfasst von Judith Lüken und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Pharmazeutische und Medizinische Chemie, Universität Münster, Corrensstraße 48, D-48149 Münster, Germany. Hauptthemen laut MEDLINE: Phenol, Receptors, N-Methyl-D-Aspartate, Indazoles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Negative allosteric modulation of GluN2B subunit-containing NMDA receptors prevents overstimulation, resulting in neuroprotective effects. Since the phenol of prominent negative allosteric modulators is prone to rapid glucuronidation, its bioisosteric replacement by an indazole was envisaged. The key step in the synthesis was a Sonogashira reaction of non-protected iodoindazoles with propargylpiperidine derivatives. Modification of the alkynyl moiety allowed the introduction of several functional groups. The synthesized indazoles showed very high GluN2B affinity but limited selectivity over σ receptors. Molecular dynamics simulations revealed the same molecular interactions with the ifenprodil binding site as the analogous phenols. In two-electrode voltage-clamp experiments, enantiomeric 3-(4-benzylpiperidin-1-yl)-1-(1H-indazol-5-yl)propan-1-ols (S)-10a and (R)-10a displayed higher inhibitory activity than ifenprodil. In contrast to phenolic GluN2B antagonists, the indazoles were not conjugated with glucuronic acid. It can be concluded that the phenol of potent GluN2B antagonists can be replaced bioisosterically by an indazole, retaining the high GluN2B affinity and activity but inhibiting glucuronidation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenolReceptors, N-Methyl-D-AspartateIndazolesBinding SitesPhenolsStructure-Activity Relationship

Substanzen

PhenolPhenolsReceptors, N-Methyl-D-AspartateIndazoles

Autor:innen und Institutionen

  • Institut für Pharmazeutische und Medizinische Chemie, Universität Münster, Corrensstraße 48, D-48149 Münster, Germany.
  • Cellular Electrophysiology and Molecular Biology, Institute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, Robert-Koch-Str. 45, D-48149 Münster, Germany.
  • GRK 2515, Chemical Biology of Ion Channels (Chembion), Universität Münster, Corrensstraße 48, D-48149 Münster, Germany.

ORCID-Profile: Gunnar Goerges, Bernhard Wünsch

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Lüken, J., Goerges, G., Ritter, N., Disse, P., Schreiber, J. A., Schmidt, J., Frehland, B., Schepmann, D., Seebohm, G., & Wünsch, B. (2023). Indazole as a Phenol Bioisostere: Structure–Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists. Journal of Medicinal Chemistry, 66(16), 11573-11588. https://doi.org/10.1021/acs.jmedchem.3c01161

Vancouver

Lüken J, Goerges G, Ritter N, Disse P, Schreiber JA, Schmidt J, et al. Indazole as a Phenol Bioisostere: Structure–Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists. Journal of Medicinal Chemistry. 2023;66(16):11573-11588. doi:10.1021/acs.jmedchem.3c01161

BibTeX
@article{Lken2023,
  author = {Lüken, Judith and Goerges, Gunnar and Ritter, Nadine and Disse, Paul and Schreiber, Julian A and Schmidt, Judith and Frehland, Bastian and Schepmann, Dirk and Seebohm, Guiscard and Wünsch, Bernhard},
  title = {Indazole as a Phenol Bioisostere: Structure–Affinity Relationships of GluN2B-Selective NMDA Receptor Antagonists},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {16},
  pages = {11573--11588},
  doi = {10.1021/acs.jmedchem.3c01161}
}
Kostenlos starten →